MedTrace Logo

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

NCT02867319 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-08-16

No results posted yet for this study

Summary

This phase I clinical study evaluates the safety of ACYW135 meningococcal polysaccharide vaccine in population aged 2-6, 7-17, 18-50 years old by the method of both passive and active surveillance.

Conditions

  • Meningococcal

Interventions

BIOLOGICAL

A dose of ACYW135 meningococcal polysaccharide vaccine

A dose of ACYW135 meningococcal polysaccharide vaccine will be given in certain arm.

Sponsors & Collaborators

  • Beijing Chaoyang District Centre for Disease Control and Prevention

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867319 on ClinicalTrials.gov